Phagos

Phagos isolates phages, sequences both phages and target bacteria, predicts their interactions with proprietary AI models and validates candidates at the bench and in real-world conditions.

The page explains what bacteriophages are, their historical use in phage therapy, and their potential future applications.

The model identifies microbial environments likely to contain undiscovered antibiotics.

For the World Economic Forum, Alexandros Pantalis explains why phage therapy needs a different kind of regulation, and what France’s platform approach to veterinary phage medicines could mean for other countries.

For the World Economic Forum, Alexandros Pantalis and Ithri Benamara explain how AI is bringing back phages, a century-old answer to resistant bacteria.

CAPHARD, Phagos’s phage-bacteria interaction model, is available on Hugging Face for querying bacterial genomes and ranking phages.

MINDS showcases AI that is already working in the real world. Phagos is one of 20 organizations in its second cohort, announced at the Forum’s Annual Meeting in Davos.

The Forum picked 100 early-stage companies from 28 countries for its 2025 cohort. Phagos is one of them, for using AI to match phages to the bacteria they kill.

Phagos aims to end bacterial disease by developing tools to analyze phage-bacteria interactions systematically.

Phagos creates foundation models trained on phage-bacteria interactions to identify phages effective against specific bacterial strains.